Affiliation:
1. Boston University School of Medicine
2. Mayo Clinic Rochester
3. Boston University School of Public Health
4. Society of Critical Care Medicine
Abstract
Abstract
Background
Little is known about the strategies used by critical care leaders to implement new practices in response to the COVID-19 pandemic. Prior studies have identified implementation factors, such as structured communication mechanisms and collaborative leadership styles, that facilitate implementation of new clinical practices. However, the association between differing implementation climates and COVID-19 clinical outcomes has not been examined. The purpose of this mixed methods study was to evaluate the relationship between implementation determinants and COVID-19 mortality rates.
Methods
We used mixed methods guided by the Consolidated Framework for Implementation Research (CFIR) to assess implementation factors that were associated with COVID-19 mortality rates across diverse critical care settings. Semi-structured qualitative interviews were conducted with critical care leaders and analyzed using the CFIR to rate the influence of constructs on implementation of new care practices. Qualitative and quantitative comparisons of CFIR construct ratings were performed between hospital groups with low versus high mortality rates.
Results
31 clinical leaders were interviewed across 17 hospitals. Of the 13 relevant CFIR constructs, three constructs (implementation climate, leadership engagement, and engaging staff) had both qualitative and statistically significant quantitative correlations with mortality outcomes. An implementation climate governed by a trial-and-error approach was correlated with high COVID-19 mortality, while leadership engagement and engaging staff were correlated with low mortality. Another three constructs (needs of patient; organizational incentives and rewards; and engaging implementation leaders) were qualitatively different across mortality outcome groups, but these differences were not statistically significant. Seven constructs did not distinguish between low versus high mortality hospitals based on qualitative or quantitative comparison of CFIR construct ratings.
Conclusions
Application of the CFIR to identify and quantify constructs across critical care settings enabled us to characterize implementation barriers and facilitators at the practice, interpersonal, and provider level that were associated with COVID-19 mortality rates. Improving clinical outcomes during future public health emergencies will require reducing identified barriers associated with high mortality and harnessing salient facilitators associated with low mortality. Our findings suggest that clinical care implementation efforts should focus on avoiding trial-and-error approaches to adopting new practices, while promoting collaborative and engaged leadership styles.
Publisher
Research Square Platform LLC
Reference38 articles.
1. COVID-19 pandemic as a watershed moment: a call for systematic psychological health care for frontline medical staff;Zaka A;J Health Psychol,2020
2. Facilitators and Barriers to the Implementation of New Critical Care Practices during COVID-19: A Multicenter Qualitative Study using the Consolidated Framework for Implementation Research (CFIR), 03 June 2022, PREPRINT (Version 2);Silver S
3. Creswell JW, Clark VLP. Designing and Conducting Mixed Methods Research. 1st ed. Thousand Oaks: Sage Publications, Inc. 274; 2007.
4. The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus 2019-Related Critical Illness;Walkey AJ;Crit Care Explor. 2020 Apr
5. Walkey AJ, Sheldrick RC, Kashyap R, Kumar VK, Boman K, Bolesta S, Zampieri FG, Bansal V, Harhay MO, Gajic O. Guiding Principles for the Conduct of Observational Critical Care Research for Coronavirus Disease 2019 Pandemics and Beyond: The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study Registry. Crit Care Med. 2020 Nov;48(11):e1038–44. doi:10.1097/CCM.0000000000004572. PMID: 32932348; PMCID: PMC7540620.